A case report of exceptional clinical response to MEK inhibition in a patient with NRAS mutation positive NSCLC

Publication

A case report of exceptional clinical response to MEK inhibition in a patient with NRAS mutation positive NSCLC

Krebs, Matthew G
;
Graham, Donna
;
Ayub, M
;
Dransfield, J
;
Frost, H
;
Aruketty, Sreeja
;
Kilerci, B
;
Wallace, A
;
Kamboj, R
;
Bakhle, D
... show 9 more

Authors

Krebs, Matthew G
Graham, Donna
Ayub, M
Dransfield, J
Frost, H
Aruketty, Sreeja
Kilerci, B
Wallace, A
Kamboj, R
Bakhle, D
Palle, V
Sharma, S
Maharaj, N
Kumawat, R
Bhonde, M
Frese, Kristopher K
Dive, Caroline
Rothwell, Dominic G
Brady, Ged

Affiliation

Experimental Cancer Medicine Team, the Christie NHS Foundation Trust, The University of Manchester and the Christie NHS Foundation Trust, Manchester, UK

Date

2018

Collections

All Christie Publications

Show all metadata

Type

Meetings and Proceedings

Citation

Krebs M, Graham D, Ayub M, Dransfield J, Frost H, Aruketty S, et al. P2.13-33 A case report of exceptional clinical response to MEK inhibition in a patient with NRAS mutation positive NSCLC. J Thorac Oncol. 2018;13(10):S811-S2.

URI

http://hdl.handle.net/10541/621497